St. John's Wort
- Generic Name
- St. John's Wort
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 84082-80-4
- Unique Ingredient Identifier
- UFH8805FKA
- Associated Conditions
- Anxiety, Burns first degree, Depression, Dermabrasion, Dermatitis, Hot Flashes, Insomnia, Myalgia, Obsessive Compulsive Disorder (OCD), Seasonal Affective Disorder (SAD), Somatic Symptom Disorders
- Associated Therapies
- -
Low Dose St John's Wort for Depression
- Conditions
- First Posted Date
- 2022-07-28
- Last Posted Date
- 2022-07-28
- Lead Sponsor
- Ceres Heilmittel AG
- Target Recruit Count
- 55
- Registration Number
- NCT05477472
- Locations
- 🇨🇭
CERES Heilmittel AG, Kesswil, Thurgau, Switzerland
Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis
- Conditions
- Interventions
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 50
- Registration Number
- NCT02840331
- Locations
- 🇩🇪
University Department of General, Visceral and Transplant Surgery, Tübingen, Baden.Württemberg, Germany
Boceprevir and Ucalm (St John&Apos;s Wort)
- First Posted Date
- 2012-08-13
- Last Posted Date
- 2014-09-29
- Lead Sponsor
- St Stephens Aids Trust
- Target Recruit Count
- 17
- Registration Number
- NCT01663922
- Locations
- 🇬🇧
St Stephen's AIDS Trust, London, United Kingdom
Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort
- Conditions
- Interventions
- First Posted Date
- 2011-04-07
- Last Posted Date
- 2017-10-05
- Lead Sponsor
- Lancaster General Hospital
- Registration Number
- NCT01330589
- Locations
- 🇺🇸
Lancaster General Hospital, Lancaster, Pennsylvania, United States
Influence of Cytochrome CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Ambrisentan
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Gerd Mikus
- Target Recruit Count
- 20
- Registration Number
- NCT01311362
- Locations
- 🇩🇪
University Hospital Heidelberg, Heidelberg, Germany
Influence of CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Bosentan
- First Posted Date
- 2010-12-13
- Last Posted Date
- 2017-05-31
- Lead Sponsor
- Gerd Mikus
- Target Recruit Count
- 13
- Registration Number
- NCT01258504
- Locations
- 🇩🇪
University Hospital Heidelberg, Heidelberg, Germany
A Placebo-Controlled Trial of St. John's Wort for Irritable Bowel Syndrome
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2010-03-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 70
- Registration Number
- NCT00587860
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
St. John's Wort in the Treatment of Raynaud's Phenomenon
- First Posted Date
- 2006-07-12
- Last Posted Date
- 2009-07-14
- Lead Sponsor
- Lawson Health Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT00351117
- Locations
- 🇨🇦
Rheumatology Clinic, St. Joseph's Health Care, London, Ontario, Canada
St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2021-09-29
- Lead Sponsor
- Wake Forest University Health Sciences
- Target Recruit Count
- 9
- Registration Number
- NCT00110136
- Locations
- 🇺🇸
Feist-Weiller Cancer Center at Louisiana State University Health Sciences, Shreveport, Louisiana, United States
🇺🇸CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸Cancer Research for the Ozarks, Springfield, Missouri, United States
Drug Interaction Study of Tegretol (Carbamazepine) and St. John's Wort in Normal Volunteers
- Conditions
- First Posted Date
- 2002-12-10
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 12
- Registration Number
- NCT00006395
- Locations
- 🇺🇸
Warren G. Magnuson Clinical Center (CC), Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.